期刊
BLOOD
卷 119, 期 7, 页码 1747-1756出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2011-09-380709
关键词
-
类别
资金
- Wellcome Trust [088410]
- Spanish Ministry of Education [EX2009-0242]
- Medical Research Council UK [U117527252]
- MRC [MC_U117527252] Funding Source: UKRI
- British Heart Foundation [PG/11/119/29299] Funding Source: researchfish
- Cancer Research UK [15689] Funding Source: researchfish
- Medical Research Council [MC_U117527252, 969735, G9818340B] Funding Source: researchfish
The C-type lectin receptor CLEC-2 signals through a pathway that is critically dependent on the tyrosine kinase Syk. We show that homozygous loss of either protein results in defects in brain vascular and lymphatic development, lung inflation, and perinatal lethality. Furthermore, we find that conditional deletion of Syk in the hematopoietic lineage, or conditional deletion of CLEC-2 or Syk in the megakaryocyte/platelet lineage, also causes defects in brain vascular and lymphatic development, although the mice are viable. In contrast, conditional deletion of Syk in other hematopoietic lineages had no effect on viability or brain vasculature and lymphatic development. We show that platelets, but not platelet releasate, modulate the migration and intercellular adhesion of lymphatic endothelial cells through a pathway that depends on CLEC-2 and Syk. These studies found that megakaryocyte/platelet expression of CLEC-2 and Syk is required for normal brain vasculature and lymphatic development and that platelet CLEC-2 and Syk directly modulate lymphatic endothelial cell behavior in vitro. (Blood.2012;119(7):1747-1756)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据